- Policy
- DREC to deliberate drug reevaluation as originally planned
- by Kim, Jung-Ju Feb 7, 2020 06:32am
- Although committee meetings and events by Korean government and associated agencies have been either canceled or postponed due to the novel coronavirus, Drug Reimbursement Evaluation Committee (DREC) plans to push on with its original schedules as it plays the role of the first threshold to drug reimbursement listing and criteria negotiation
- Policy
- 2019n-CoV was successfully isolated from infected patients
- by Kim, Jung-Ju Feb 6, 2020 06:30am
- Health authorities have successfully isolated the new coronavirus (wuhan pneumonia) from patients with infectious diseases, It is very good news for developing vaccines and treatments The KCDC(Director, Eun-kyung Chung) announced on the 5th that 2019n-CoV was isolated and will share with the scientific community for the development of vaccine
- Policy
- Illegal botulinum toxin dealing salesmen sent to prosecutor
- by Lee, Tak-Sun Feb 5, 2020 05:58am
- A couple of salespeople from a pharmaceutical company were caught red-handed illegally supplying botulinum toxin injections, used to reduced wrinkles, to unlicensed vendors. Korea’s Ministry of Food and Drug Safety (MFDS, Minister Lee Eui-kyung) announced on Jan. 3, it sent two salesmen, aged 44 and 40, and four unlicensed brokers to pro
- Policy
- The KOEDC, real-time check on 2019-nCoV treatment
- by Lee, Jeong-Hwan Feb 5, 2020 05:58am
- The KOEDC (President Young-mi Yoon) said it is checking the overseas status of alternative treatment candidates such as antiviral agents in real time in order to cope with a 2019-nCoV infection known to have no treatment. As the agency is in charge of domestic supply and demand of rare medicines worldwide, it is intended to support the rap
- Policy
- Insurance not covered if Revlimid prescribed multiple up
- by Lee, Hye-Kyung Feb 4, 2020 08:16pm
- Insurance will not be covered if Revlimid’s lower dose such as 5mg in multiples by Celgene is prescribed instead of Revlimid 10mg, 15mg, 20mg, or 25mg. Reimbursed price of Revlimid 25mg is &8361;101,768, whereas Revlimid 2.5mg, 1/10 dose of Revlimid 25mg, is &8361;53,904. If 10 tablets of Revlimid 2.5mg is prescribed instead of 1 table
- Policy
- Patent litigation to decide prospects of Olostar generic
- by Lee, Tak-Sun Feb 4, 2020 06:32am
- For the first time, a generic drug with same active ingredient (olmesartan medoxomil, rosuvastatin calcium) contained in Daewoong Pharmaceutical’s blockbuster co-morbid hypertension and dyslipidemia treatment, Olostar, has applied for approval. Presumably, the generic manufacturer would be either Kolmar Korea or a CMO as Kolmar Korea’s
- Policy
- The HIRA approved 10 of 12 cases in Spinraza
- by Lee, Hye-Kyung Feb 4, 2020 06:31am
- Ten out of 12 applications for the 'Spinraza' reimbursement, which has a maximum insurance price of &8361;92.3 million, were approved. One case was failed, and one case was withheld due to a request for supplementary data. The HIRA (Director Seung-Taek Kim) released result of deliberation example on the website on the 31st including ▲ Immun
- Policy
- Value framework research explains why we need it
- by Lee, Hye-Kyung Feb 3, 2020 06:24am
- Experts claim value framework criteria and evidence fitting to Korean circumstances are needed to justify limited National Health Insurance (NHI) finance granting reimbursement on high-cost anticancer treatment with clinical uncertainty. The argument is that new value framework scales are needed for a new high-cost anticancer treatment with
- Policy
- 6-hour test kit targeting 2019-nCoV developed in Korea
- by Lee, Tak-Sun Feb 3, 2020 06:24am
- A laboratory test kit to confirm the 2019 novel coronavirus infection in six hours has been co-developed by a government body and private entity. From Jan. 31, the new test kit would used by Korea Centers for Disease Control and Prevention (KCDC) and Government Research Institute of Public Health and Environment to test suspected cases, and
- Policy
- Government on new coronavirus, “All hands on deck”
- by Kim, Jung-Ju Feb 3, 2020 06:22am
- The Korean government body reported the Cheongwadae of pan-government response plan on the 2019 novel coronavirus after monitoring the current status of the outbreak. Along with the plan, the government officials discussed of a plan evacuating Korean residents in Wuhan, China, and providing other humanitarian support for China. At th
